AF
Alexander A Fitzpatrick
Chief Legal Officer

Alexander A Fitzpatrick insider trades: ARS Pharmaceuticals (SPRY) stock buys and sales

Chief Legal Officer, ARS Pharmaceuticals Last trade Jun 12, 2026 40 Form 4 filings
$34K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2011
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Alexander reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 12, 2026SPRY↓ Sell$34K
May 20, 2025SPRY↓ Sell$1.5M
Sep 29, 2023SPRY↑ Buy$320K
Dec 20, 2021EVFM↑ Buy$10K
Jun 10, 2021EVFM↑ Buy$10K
Nov 17, 2020EVFM↑ Buy$20K
Aug 21, 2018EVFM↑ Buy$11K
Aug 19, 2011VRNM↑ Buy$14K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SPRY insiders

Open-market trades in the last 12 months

About Alexander A Fitzpatrick's insider trades

Alexander A Fitzpatrick is Chief Legal Officer at ARS Pharmaceuticals (SPRY). Since Aug 19, 2011, Alexander has reported 6 open-market purchases worth $385K and 2 sales worth $1.5M on SEC Form 4. In the last 12 months: 1 sale ($34K).

Their filings also include grants and awards (18 filings), shares withheld for taxes (11 filings), shares returned to the company (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SPRY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.